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ABSTRACT
Previous study has shown that -terpineol has a cytotoxic effect on NCI-H69 cancer cell line.
This study aimed to evaluate cytotoxicity, proapoptotic, and antiproliferative activities of -
terpineol in T47D cell lines. The cytotoxic activity of -terpineol was determined using MTT cell
viability assay, while apoptosis was tested by the acridine orange-ethidium bromide staining
method. The cell cycle was evaluated by flowcytometry method. The results showed that -
terpineol had cytotoxic effect on the T47D cells with the IC50 value of 135.00 ± 8.74 M.
Furthermore,-terpineol induced the cells apoptosis in a dose-dependent manner. Flowcytometry
analysis showed that -terpineol induced the T47D cell distribution in Go/G1 phase, however
inhibited cell distribution in S phase. This study suggests that-terpineol has a potential anticancer
activity.
ABSTRAK
Penelitian sebelumnya menunjukkan bahwa -terpineol mempunyai efek sitotoksik pada sel
kanker NCI-H69. Penelitian ini bertujuan mengkaji aktivitas sitotoksisitas, proapoptotik dan
antiproliferatif dari alpfa terpinol in sel kanker T47D. Aktivitas sitotoksisitas-terpineol ditentukan
dengan MTT cell viability assay, sedangkan apoptosis diuji dengan metode pewarnaan akridin
oranye-etidium bromida. Siklus sel dievaluasi dengan metode flowsitometri. Hasil penelitian
menunjukkan -terpineol mempunyai efek sitotokik pada sel T47D dengan nilai IC50 135,00 ±
8.74 M. Selain itu -terpineol menginduksi apoptosis yang bergantung konsentrasi. Analisis
flowsitometri menunjukkan -terpineol menginduksi distribusi sel T47D pada fase Go /G1, namun
demikian menghambat distribusi sel pada fase S. Penelitian ini menunjukkan bahwa -terpineol
mempunyai aktivitas antikanker potensial.
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INTRODUCTION
Cancer remains as a major health problem
in the world. In the United States, 1,529,560
cases of cancer were reported with 569,490
deaths in 2010.1 These cases have increased
over the previous year amounting to 562,341.2
Furthermore, it was estimated that by 2030, the
cancer cases will reach approximately 26
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million cases and 17 million deaths around the
world.3
Breast cancer is the most common cancer
in women.1 In the 2007 data obtained from
Dharmais Hospital, National Cancer Center,
Jakarta, it was indicated that 437 breast cancer
patients had been hospitalized among a total of
1,264 outpatients.4 Gerber et al.5 reported that
40% of patients experienced recurrence of
breast cancer and most of them died from it.
Breast cancer is one of the cancers with the
highest incidence of death in the world. In 2004,
it was reported that there were 519,000 deaths
due to breast cancer around the world.6
Chemotherapy is one of the breast cancer
managements which is normally performed in
conjunction with surgery and radiotherapy.7
However, chemotherapy owns disadvantages
ranging from adverse or toxic effects of
anticancer to patients’ death.8 Moreover,
resistance to anticancer remains a major
problem in chemotherapy. The problems in
chemotherapy make the availability of a new
anticancer that is more sensitive and specific
urgently needed. One of the strategies in the
search for new anticancer molecules is
exploration of active constituents from natural
resources.9
-Terpineol is one potential natural
anticancer isolated from Pinus merkusii, an
endogenous Indonesian plant. The potency of
-terpineol as anticancer candidate has been
reported by some authors.-Terpineol and two
other active constituents namely linlyl acetate
and camphor isolated from Salvia libanotica
have been proven to be able to induce cell cycle
and apoptosis of colon cancer HCT-116 cells
in vitro through caspase activation, cytochrome-
c release and PARP cleavage.10 In addition, the
study of Hassan et al.11 proved that-terpineol
is able to prevent the MCF-7 and HeLa cells
growth by inhibiting NF-kB signaling pathway.
-Terpineol, which is derived from the sap
processing of P. merkusii , is relatively
abundant.12-Terpineol is the major component
of terpineol which is usually present in a
mixture of three isomers namely-,- and-
terpineol.13 Terpineol can be synthesized from
turpentine oil which is a non timber product of
P. merkusii obtained from the sap without
having to chop down the tree. This study was
conducted to evaluate the cytotoxicity of the-
terpineol synthesized from turpentine oil in
TD47D cancer cell lines. The effect of the-
terpineol on the apoptosis and proliferation of
the T47D cells were also evaluated.
MATERIALS AND METHODS
Chemicals
-Terpineol was obtained and synthesized
by Prof Arief Budiman from Department of
Chemical Engineering, Faculty of Engineering,
UniversitasGadjahMada.Doxorubicin (Ebedoxo,
Ebewe Pharma), RPMI 1640 medium (Gibco),
fetal bovine serum (FBS) (Gibco), amphotericin
B (Gibco), L-glutamine (Sigma-Aldrich),
penicillin-streptomycin (Penstrep®-Gibco),
trypsin EDTA (Gibco), 4-(2-hydrocyethyl)-
piperazine-ethane) sulphonic acid (HEPES)
(Sigma-Aldrich), sodium bicarbonat (Nacalai
Tesque), phosphate buffer saline (PBS)
(Invitrogen), MTT (3-(4,5-dimethylthiazol-2-
yl)-2,5-diphenyltetrazolium bromide) (Bio
Basic Inc.), sodium dodesil sulfat (SDS)
(Merck), acid chloride (Merck), ethidium
bromide (Promega Corp.), acridine orange
(Sigma-Aldrich), and propidium iodide reagent
(Becton-Dickinson) were used in this study.
Cell cultures
T47D cells were cultured in culture flasks
containing complete RPMI-1640 medium
supplemented with 10% FBS, 2 mM L-
glutamine, 100g/mL of streptomycin, and 100
mg/mL of penicillin. Cultures were maintained
in 5% CO2 incubator at 37°C and fed every 3
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days with complete RPMI 1640 medium.
Confluent cells were trypsinized, and harvested
cells were used for experiments.
MTT assay
Cytotoxicity of-terpineol was evaluated
on TD47D cells using the MTT assay as
reported by Mosmann after modification.14 Cells
were distributed in 96-wells microplates at 1 x
104 cells per well in 100 mL and then 100 mL
of complete RPMI 1640 medium were added.
The cell cultures were then incubated in 5%
CO2 incubator at 37
oC for 24 hours. After
incubation, the medium was removed and
replaced with new complete RPMI 1640
medium containing various concentrations of-
terpineol. Cells culture and -terpineol were
then incubated again in 5% CO2 incubator at
37oC for 24 hours. After the incubation, the
medium was removed and the cells were
resuspended in RPMI 1640 medium, 10 mL of
5 mg/mL MTT [3-9,4,5-dimethylthiazole-2-yl-
2,5-diphenyltetrazolium bromide] and then
further incubated for 4 hours. The reaction was
stopped by adding 100 mL of 10% sodium
dodecyl sulfate (SDS) in 0.01N HCl.
Microculture plates were then shaken gently for
5 minutes, covered with aluminium foil and
incubated at room temperature overnight.
Absorbance of the microculture plates was
measured in an ELISA plate reader atmax 595
nm. The absorbance values were directly
proportional to the number of live cells. The
absorbance values in the presence of -
terpineol were compared with that of control
cultures without -terpeniol to obtain cells
growth inhibition. For this MTT method, IC50
values were determined by probit analysis
based on the relationship between log
concentrations versus the percentage of cells
growth inhibition. Doxorubicin was used as
positive control.
Apoptotic assay
The acridine orange-ethidium bromide
staining method was used to observe the
apoptotic morphologic changes as reported by
Ribble, et al.15 T47D cells were suspended at
a final concentration of 5 x 104/mL in complete
RPMI 1640 medium and distributed in 24-wells
plates coated with coverslip at the bottom. The
cells were then treated with 1000 µL of -
terpineol at a concentration equivalent with the
IC50 value (135 µM) and incubated in 5% CO2
incubator at 37°C for 15 hours. Doxorubicin at
a concentration of 17.89 µM was used as
control. After incubation, the medium was
removed and the cells were washed gently with
PBS. Coverslip containing the treated cells
were removed to glass object and then stained
with 100 µL of mixture of acridine orange-
ethidium bromide in PBS solution. The cells
were observed under a fluorescence micros-
cope. The apoptotic cells would emit orange
fluorescence and the viable cells would emit
green fluorescence. The number of cells
undergoing apoptosis was observed in at least
three microscopes field of view and the
percentage of apoptotic was calculated.
Cells cycle analysis
Cells cycle analysis was performed by
flowcytrometry. Two small tubes were prepared
for each treatment. T47D cell line were seeded
onto 6-well plates at density of 7 x 105 cells
per well and incubated in 5% CO2 incubator at
37°C overnight.After overnight incubation, the
T47D cells culture were treated with 500 µL of
-terpineol at 2 different concentrations which
were equivalent to the value of ½ IC50 (67.5
µM) and IC50 (135 µM) for 24 hours. After
incubation, the cells were collected and
harvested.After centrifugation, cell pellets were
washed twice with 500 µL of cold PBS. Cells
were then incubated with 400L of propidium
iodide reagent at 37°C for 10 minutes and
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transferred to flowcytotube. The cells were
immediately analyzed by FACS Calibur
flowcytometer to evaluate cell cycle profile.
Flowcytometric data were analyzed using Cell
Quest to evaluate the cells distribution at each
phase of the cell cycle namely the sub G1
(apoptosis), S, G2/M, and the cells undergoing
polyploidy. The cell cycle inhibition was
observed by comparing the cells distribution at
G0/G1 and G2/M phases of treated and untreated
cells. The protocol of the study has been
approved by the Medical and Health Research
Ethics Committee, Faculty of Medicine,
Universitas Gadjah Mada, Yogyakarta.
Statistical analysis
Data were expressed as the mean ± standard
deviation (SD). Statistical comparisons were
performed using Student’s t-test, and differences
between groups were considered significant at
a value of <0.05.
RESULTS
The growth inhibition of TD47D cells in
vitro after incubation with -terpineol or
doxorubicin in various different concentrations
for 24 hours in 5% CO2 incubator at 37° C is
presented in TABLE 1. This study showed that
-terpineol or doxorubicin inhibited the T47D
cells growth in a dose-dependent manner. In the
highest concentration of-terpineol (450 µM),
the growth inhibition reached 96.03%, while
for doxorubicin (172.40 µM), the growth
inhibition reached 83.3%. Statistical analysis
showed that the IC 50 value of -terpineol
(135.00 ± 8.74 µM) was significantly higher
than doxorubicin (17.89 ± 0.45 µM) (p<0.05).
TABLE 1. The average value of growth inhibition of T47D cells (% ± SD) after
24 hours incubation with the a-terpineol and doxorubicin and its IC50
value (µM)
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To evaluate the effect of-terpineol on the
apoptosis, T47D cells were analyzed in the
presence of acridine orange-ethidium bromide
staining. Morphologic observation after staining
is presented in FIGURE 1. Green-stained T47D
cells represent viable cells, whereas orange
staining represents apoptotic cells. -Terpineol
at concentration of 135 µM induced 50.53%
apoptosis of the T47D cells, whereas doxorubi-
cineatconcentrationof17.89µMinduced51.33%
apoptosis of the cells (TABLE 2).
The effect of -terpineol on the T47D cell
cycle progression was evaluated by cell
flowcytometry. FIGURE 1 and TABLE 3 show
the T47D cell cycle profile after treatment with á-
terpineol at 2different concentrations (135.00 and
67.50 µM) and doxorubicin at 17.89 µM.TABLE
3 shows that there was a significant increase in
the number of cell distributions in G0/G1 phase
after treatment with-terpineol from 38.17± 1.05
% to 50.98±1.60% at concentration of 67.50 µM
and 56.89±1.93% at concentration 135.00 µM. In
contrast, significant decrease was observed in S
phase, from 19.35±0.21% to 18.39±0.35% and
15.34±0.72% at concentration 67.50 and 135.00
µM, respectively. Moreover, significant decrease
in G2/M was also observed to be from 33.05±
1.46% to 24.62±0.96% and 18.84±0.68% at
concentration 67.50 and 135.00 µM, respectively.
FIGURE 1. Morphologic observation with ethidium
bromide-acridine orange staining T47D
cells were treated without (A) and with a-
terpineol (B). Viable cells are indicated by
green color ( ) and apoptotic cells are
indicated by orange color ( ). The obser-
vations used a fluorescent microscope
with magnification of 100x.
TABLE 2 The percentage of apoptotic T47D cells
after treated with and without b-terpineol
or doxorubicin.
FIGURE 2. The percentage of T47D cell distribution
(mean ± SD) in each cells cycle phase after
treated with a-terpineol at concentration
67.5 and 135.0 µM and doxorubicin at
concentration 17.89 µM for 24 hours after
analyzed by flowcytometry
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TABLE 3. The percentage of T47D cell distribution (mean ± SD) in each cells cycle phase after treated
with-terpineol at concentration 67.5 and 135.0 µM and doxorubicin at concentration 17.89
µM for 24 hours after analyzed by flowcytometry
DISCUSSION
This study showed that-terpineol inhibited
the T47D cell growth in a dose-dependent
manner. In the lowest concentration,-terpineol
(50 µM) yielded the inhibition of cell growth
of 17.89 ± 6.79%, while in highest
concentration, it yielded 96.03 ± 0.74%. Further
analysis demonstrated that the cytotoxicity of
-terpineol on the T47D cells (IC50:135.00 ±
8.74 µM) was significantly lower than
doxorubicin (IC50: 17.89±0.45 µM) as positive
control. However, the cytotoxicity of -
terpineol on T47D cells obtained from this study
was higher than the cytotoxicity on NCI-H69
lung cancer cells (IC50: 260 µM) as reported
by Hassan et al.11 America National Cancer
Institute classifies a compound as a potential
candidate for anticancer if it has IC50 value less
than 30 µg/mL.16 Based on this criteria, -
terpineol that has IC50 135 µM or equivalent
with 20.28 µg/mL, can be categorized as a
potential anticancer compound.
Apoptosis is a cellular mechanism that is
useful for eliminating permanent damage of the
cells without causing inflammation.17,18It is an
important homeostatic mechanism that balances
cell division and cell death and maintains the
appropriate cell number in the body.19 Some
anticancers cause the death of sensitive cells
through the induction of apoptosis. Therefore,
induction of apoptosis is one of mechanisms
expected in the development of new
anticancers.20 In this study, the effect of -
terpineol on induction of apoptosis in T47D
cells has been also evaluated.
Double staining test with ethidium bromide-
acridine orange was selected in this study to
evaluate the -terpineol-induced apotosis
because of its ease, speed and accuracy.15 The
T47D cells staining green represented viable
cells, whereas orange staining represented
apoptosis cells. The T47D cells treated with
135.00 µM of -terpineol showed changes in
cellular morphology including chromatin
condensation, membrane blebbing, and
fragmented nuclei (FIGURE 1B) as reported by
Ribble et al.15 and Renvoize et al.21 In contrast,
in the untreated T47D cells or cells control
(FIGURE 1A), all cells stained green and no
orange staining cells were observed indicating
no apoptotic cells.
The fragmentation of nuclei represents DNA
fragmentation which is a marker of the end of
apoptosis after activation of caspase proteins.
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DFF40 is responsible for DNA fragmentation
after DFF45 (DFF40 binding) protein cleaved
by caspase 3/7 protein.22 T47D cell consists of
caspase 3 protein (a major mediator of
apoptosis). Activation of caspase pathways are
also triggered by cutting other essential proteins
such as PARP (poly-ADP-ribose polymerase),
which functions as a DNA repair enzyme.23
The regulation of cell cycle is crucial in
the growth and development of cancer. In this
study the effect of-terpineol on the T47D cell
cycle progression was evaluated by
flowcytometry method. The results showed that
the -terpineol induced the T47D cell
distribution in Go/G1 phase and inhibited cell
distribution in S phase. The effect of-terpineol
on cell cycle has been also reported by Hassan
et al.11-Terpineol inhibiting the proliferation
of lymphoma U937-GTB cancer cells in G0/G1
phase leads to a reduction in the number of cells
in the later stages of cell cycle (S, G2 and M) as
shown in this study.
Hassan et al.11 also demonstrated that-
terpineol exhibited a potential anticancer which
acts by suppressing NF-B which signals
various cancer cells line. NF-B protein is one
of transcription factors that are involved in the
control of inflammatory responses, develop-
mental processes, cellular growth and apopto-
sis.24-Terpineol inhibits NF-B translocation
and activity and down-regulates the expression
of several NF-B-related genes such as IL-1
and IL1R1 resulting in the inhibition of cancer
cells growth.11
CONCLUSION
In conclusion, these findings suggest that á-
terpineol has a potential anticancer activity.
Further study concerning the mechanism of the
anticancer action and specificity of-terpineol
will be conducted. In addition, the in vivo
anticancer activity of -terpineol on animal
cancer model should be the subject of further
study.
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